혈액 분석기 및 시약 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품 및 서비스별, 가격대별, 사용 유형별, 용도별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)
Hematology Analyzers and Reagents Market Size, Share, Trends, Industry Analysis Report: By Product and Services, Price Range, Usage Type, Application, End User, and Region - Market Forecast, 2025-2034
상품코드:1625366
리서치사:Polaris Market Research
발행일:2024년 12월
페이지 정보:영문 128 Pages
라이선스 & 가격 (부가세 별도)
한글목차
Polaris Market Research의 최신 조사에 따르면, 혈액 분석기 및 시약 시장 규모는 2034년까지 117억 8,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
혈액 분석기 및 시약 시장의 성장은 혈액 관련 질환 및 만성질환의 유병률 증가와 세계 헬스케어 수요 증가에 힘입어 성장하고 있습니다. 혈액 분석기 및 시약은 정기적인 혈액 분석이 필요한 빈혈, 백혈병, 감염성 질환 등의 진단 및 모니터링에 중요한 역할을 합니다. 환자의 예후를 개선하기 위해 보다 빠르고 정확한 진단 과정을 가능하게 하는 기술 혁신과 자동화의 발전은 혈액 분석기 및 시약에 대한 시장 기회를 창출할 것으로 예상됩니다. 고령 인구의 증가는 혈액 모니터링이 필요한 질병에 걸리기 쉬워 시장 성장의 원동력이 되고 있습니다. 또한, 신흥국의 의료 인프라 투자 증가는 향후 몇 년 동안 시장 확대를 촉진할 것으로 보입니다.
자동화와 현장 검사(POCT)의 기술 발전으로 의료 서비스 제공자는 원격지에서도 효율적이고 시기적절한 진단을 제공할 수 있게 되었으며, 이는 예측 기간 동안 혈액학 분석기 및 시약 시장의 트렌드로 부상할 것으로 보입니다. 혈액학 분석기에 인공지능을 접목하면 진단 정확도가 향상되어 업계 기업의 수익 성장을 촉진할 것으로 예상됩니다. 또한, 의료 서비스 제공자와 진단 연구소가 더 많은 검사량을 처리하기 위해 노력함에 따라 처리량이 많고 사용자 친화적인 분석기에 대한 수요가 급증할 것으로 예상됩니다.
주요 기업들은 증가하는 진단 수요에 대응하기 위해 연구개발과 전략적 제휴에 집중하여 보다 효율적이고 비용 효율적이며 정확한 혈액학 솔루션을 개발하고 있습니다. 경쟁 환경은 기술 혁신과 지역 간 다양한 진단 요구에 맞는 신제품 도입으로 특징지어집니다. 이러한 모든 요인으로 인해 혈액 분석기 및 시약 시장은 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상됩니다.
혈액 분석기 및 시약 시장 보고서 하이라이트
제품 및 서비스별로는 혈액 질환의 유병률 증가와 진단 기술의 발전으로 인해 혈액학 제품 및 서비스 분야가 2024년 혈액 분석기 및 시약 시장에서 가장 큰 점유율을 차지했습니다.
사용 유형에 따른 독립형 부문은 유연성, 비용 효율성, 확장성을 제공하는 독립적이고 사용하기 쉬운 솔루션에 대한 선호도가 높아짐에 따라 예측 기간 동안 더 높은 CAGR을 기록할 것으로 예상됩니다.
2024년 북미는 첨단 의료 인프라의 존재로 인해 혈액 분석기 및 시약 시장을 장악했습니다.
아시아태평양 시장은 혁신적 기술 채택과 연구개발에 대한 투자 증가로 인해 예측 기간 동안 큰 성장을 보일 것으로 예상됩니다.
세계 주요 시장 진입 기업으로는 Sysmex Corporation, Danaher Corporation, Nihon Kohden Corporation, Siemens Healthineers, Abbott Laboratories, Boule Diagnostics AB, Horiba, Ltd., Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and F. Hoffmann-La Roche Ltd. 등이 있습니다.
The hematology analyzers & reagents market size is expected to reach USD 11.78 billion by 2034, according to a new study by Polaris Market Research. The report "Hematology Analyzers and Reagents Market Share, Size, Trends, Industry Analysis Report: By Product and Services (Hematology Products & Services, Hemostasis Products & Services, and Immunohematology Products & Services), Price Range, Usage Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The hematology analyzers and reagents market growth is driven by the increasing prevalence of blood-related disorders and chronic diseases and rising healthcare demands worldwide. Hematology analyzers and reagents play a vital role in diagnosing and monitoring conditions such as anemia, leukemia, and infections, which require regular blood analysis. Advancements in technological innovation and automation that enable faster, more precise diagnostic processes to enhance patient outcomes are expected to create the hematology analyzers and reagents market opportunities. Rising geriatric population is more susceptible to diseases requiring blood monitoring, which drives market growth. Also, increasing healthcare infrastructure investments in emerging economies would propel market expansion in the coming years.
Technological advancements in automation and point-of-care testing (POCT) allow healthcare providers to deliver efficient and timely diagnostics, even in remote settings, which would emerge as the hematology analyzers and reagents market trends during the forecast period. Integrating artificial intelligence into hematology analyzers is expected to improve diagnostic accuracy, driving revenue growth for companies in the industry. Moreover, as healthcare providers and diagnostic laboratories strive to handle larger testing volumes, the demand for high-throughput, user-friendly analyzers increases sharply.
Leading companies are focused on R&D and strategic partnerships to meet the increasing diagnostic demands, creating more efficient, cost-effective, and accurate hematology solutions. The competitive landscape is marked by innovation and the introduction of new products tailored to meet diverse diagnostic needs across regions. Thus, owing to all the factors mentioned above, the hematology analyzers and reagents market is expected to achieve robust growth in the coming years.
Hematology Analyzers and Reagents Market Report Highlights
In terms of product and services, in 2024, the hematology products & services segment accounted for the largest hematology analyzers and reagents market share due to the increasing prevalence of blood disorders and advancements in diagnostic technologies.
The standalone segment, based on usage type, is expected to witness a higher CAGR during the forecast period due to the growing preference for independent, easy-to-use solutions that offer flexibility, cost-effectiveness, and scalability for various applications across industries.
In 2024, North America dominated the hematology analyzers and reagents market due to the presence of advanced healthcare infrastructure.
The Asia Pacific market is expected to witness significant growth during the forecast period due to the high adoption of innovative technologies and increased investments in research and development.
A few global key market players are Sysmex Corporation; Danaher Corporation; Nihon Kohden Corporation; Siemens Healthineers; Abbott Laboratories; Boule Diagnostics AB; Horiba, Ltd.; Bio-Rad Laboratories Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; and F. Hoffmann-La Roche Ltd.
Polaris Market Research has segmented the hematology analyzers and reagents market report on the basis of product and services, price range, usage type, application, end user, and region:
By Product and Services Outlook (Revenue, USD Billion; 2020-2034)
Hematology Products & Services
Instruments
5-Part and 6-Part Fully Automated Hematology Analyzers
3-Part Fully Automated Hematology Analyzers
Point-of-Care Testing Hematology Analyzers
Semi-Automated Hematology Analyzers
Reagents and Consumables
Hematology Reagents
Slide Stainers/Makers
Controls and Calibrators
Consumables
Services
Hemostasis Products & Services
Instruments
Reagents & Consumables
Services
Immunohematology Products & Services
Instruments
Reagents & Consumables
Services
By Price Range Outlook (Revenue, USD Billion; 2020-2034)
High Range Hematology Analyzers
Mid-Range Hematology Analyzers
Low- Range Hematology Analyzers
By Usage Type Outlook (Revenue, USD Billion; 2020-2034)
Standalone
POCT
By Application Outlook (Revenue, USD Billion; 2020-2034)
Anemia
Blood Cancer
Hemorrhagic Conditions
Infectious Diseases
Immune System Disorders
Other Applications
By End User Outlook (Revenue, USD Billion; 2020-2034)
Hospital Laboratories
Commercial Service Providers
Government Reference Laboratories
Research & Academic Institutes
By Regional Outlook (Revenue, USD Billion; 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Hematology Analyzers and Reagents Market Insights
4.1. Hematology Analyzers and Reagents Market - Application Snapshot
4.2. Hematology Analyzers and Reagents Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Blood Disorders and Chronic Diseases
4.2.1.2. Rising Aging Population
4.2.2. Restraints and Challenges
4.2.2.1. High Cost of Advanced Hematology Analyzers
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Hematology Analyzers and Reagents Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Hematology Analyzers and Reagents Market, by Product and Services
5.1. Key Findings
5.2. Introduction
5.2.1. Global Hematology Analyzers and Reagents Market, by Product and Services, 2020-2034 (USD Billion)
5.3. Hematology Products & Services
5.3.1. Global Hematology Analyzers and Reagents Market, by Hematology Products & Services, by Region, 2020-2034 (USD Billion)
5.3.2. Instruments
5.3.2.1. Global Hematology Analyzers and Reagents Market, by Instruments, by Region, 2020-2034 (USD Billion)
5.3.2.2. 5-part and 6-part Fully Automated Hematology Analyzers
5.3.2.2.1. Global Hematology Analyzers and Reagents Market, by 5-part and 6-part Fully Automated Hematology Analyzers, by Region, 2020-2034 (USD Billion)
